Display options
Share it on

Iran J Reprod Med. 2014 Oct;12(10):681-6.

Altered of microRNA expression level in oligospermic patients.

Iranian journal of reproductive medicine

Alireza Abhari, Nosratollah Zarghami, Laya Farzadi, Mohammad Nouri, Vahideh Shahnazi

Affiliations

  1. Department. of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  2. Women's Reproductive Health Research Center, Al-zahra Hospital, Tabriz University of Medical Sciences, Tabriz, Iran .

PMID: 25469126 PMCID: PMC4248154

Abstract

BACKGROUND: MicroRNA (miRNA) is small endogenous, single strand RNA molecules that regulate gene expression at post-transcriptional level through several mechanisms to affect key cellular event including male germ cells differentiation, proliferation, development and apoptosis. Mutation and/or aberrant expression of miRNAs have been associated with progression of various disorders, including infertility.

OBJECTIVE: The purpose of this research was to study the estrogen receptor beta (ERβ(, hsa-mir-21 and, hsa-mir-22 expression level in oligospermic infertile and control fertile men and correlation between them.

MATERIALS AND METHODS: In this study, the change in mir-21, mir-22 expression and their common target gene (ERβ) expression levels were evaluated in oligospermic infertile men (n= 43) compared with 43 age matched healthy control by Real-Time PCR methods.

RESULTS: Expression analysis by qRT-PCR test on miRNA have identified that mir-21, mir-22 levels were significantly higher than those in normal controls (p<0.0001) and ERβ expression level significantly decreased in comparison with the normal group (p<0.0001).

CONCLUSION: Our study showed that mir-21 and mir-22 are indirectly involved in spermatogenesis by regulating of the estrogen receptor and might have a diagnostic and prognostic value in men infertility.

Keywords: Fertility; Oligospermia; microRNA; mir-21; mir-22

References

  1. Nat Rev Mol Cell Biol. 2010 Apr;11(4):252-63 - PubMed
  2. Cell Mol Life Sci. 2009 Aug;66(15):2405-26 - PubMed
  3. Mol Cell Biochem. 2011 Nov;357(1-2):31-8 - PubMed
  4. Int J Oncol. 2013 Jan;42(1):219-28 - PubMed
  5. Dev Growth Differ. 2004 Oct;46(5):459-70 - PubMed
  6. Semin Cell Dev Biol. 1998 Aug;9(4):411-6 - PubMed
  7. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 - PubMed
  8. Asian J Androl. 2010 Jan;12(1):47-58 - PubMed
  9. Steroids. 2010 Dec;75(12):998-1004 - PubMed
  10. Nucleic Acids Res. 2009 Aug;37(14):4850-61 - PubMed
  11. Endocrinology. 1996 Nov;137(11):4796-805 - PubMed
  12. J Androl. 2005 Jan-Feb;26(1):70-4 - PubMed
  13. Reprod Sci. 2012 Jan;19(1):31-42 - PubMed
  14. Environ Health Perspect. 2000 Oct;108(10):961-6 - PubMed
  15. Folia Histochem Cytobiol. 2007;45 Suppl 1:S5-10 - PubMed
  16. Reproduction. 2006 Sep;132(3):477-84 - PubMed
  17. Nucleic Acids Res. 2001 May 1;29(9):e45 - PubMed
  18. Arch Androl. 1992 Jan-Feb;28(1):15-7 - PubMed
  19. Reprod Biol Endocrinol. 2009 Feb 11;7:13 - PubMed
  20. Am J Clin Pathol. 2011 Aug;136(2):247-51 - PubMed
  21. Hum Mol Genet. 2000 Sep 1;9(14):2183-7 - PubMed
  22. Int J Androl. 2010 Aug 1;33(4):642-9 - PubMed
  23. Reprod Domest Anim. 2012 Oct;47(5):782-90 - PubMed
  24. J Mol Med (Berl). 2009 Jul;87(7):735-48 - PubMed
  25. Arch Androl. 2007 May-Jun;53(3):161-7 - PubMed
  26. Mol Cell Endocrinol. 2013 Sep 5;377(1-2):33-43 - PubMed
  27. Acta Eur Fertil. 1992 May-Jun;23(3):117-21 - PubMed
  28. Biol Reprod. 2008 Jan;78(1):101-14 - PubMed
  29. Front Biosci (Schol Ed). 2012 Jun 01;4:1266-74 - PubMed
  30. Reprod Biomed Online. 2011 Feb;22(2):103-5 - PubMed
  31. Toxicol In Vitro. 2010 Jun;24(4):1168-75 - PubMed
  32. J Androl. 2012 May-Jun;33(3):309-37 - PubMed
  33. PLoS One. 2012;7(4):e35553 - PubMed
  34. Biol Reprod. 2006 Dec;75(6):877-84 - PubMed

Publication Types